What We're Reading: Page 4
Industry reads hand-picked by our editors
Aug 04, 2025
-
The Wall Street Journal
How Trump’s ‘Big Beautiful Bill’ Will Keep Drug Prices Higher Longer and Cost Medicare Billions
-
Stat News
FDA’s top cancer drug regulator played key role in rejection of Replimune therapy
-
MedTech Dive
Heartflow prices IPO, aiming to net about $180M
-
The Washington Post
There’s another risk to your heart that’s getting new attention
Aug 01, 2025
-
The Washington Post
Medicare, Medicaid to experiment with covering weight loss drugs
-
BioSpace
Merck’s $3B Savings Push Claims 6,000 Jobs
-
Financial Times
Switzerland in ‘shock’ at 39% US tariff blow
Jul 31, 2025
-
Politico
Trump drove firing of FDA official
-
Bloomberg
AbbVie in Talks to Acquire Gilgamesh in $1 Billion Deal
-
The Wall Street Journal
Can Novo Nordisk’s New CEO Stop Rivals From Taking Over the Anti-Obesity Market?
Jul 30, 2025
-
Stat News
Biotech says its cholesterol drug shows signs of preventing Alzheimer’s
-
Reuters
US Senate Democrats to investigate Kennedy’s firing of vaccine expert panel
-
The New York Times
William J. Rutter, Biotech Pioneer of Gene-Based Medicine, Dies at 97
-
ScienceNews
A molecule produced by gut microbes may help spur heart disease
Jul 29, 2025
Jul 28, 2025
-
The Wall Street Journal
RFK Jr. to Oust Advisory Panel on Cancer Screenings, HIV Prevention Drugs
-
BioSpace
Drug Pricing Just One Point of Confusion Over New FDA Vouchers
-
SFGate
Layoffs, shutdowns and billions up in smoke. What’s wrong with Bay Area biotech?
-
MedPage Today
There’s a Major Publishing Slowdown at CDC’s Flagship Journal
Previous
